Our advanced functional genomics platform offers comprehensive tools for drug discovery, including genome editing, RNA interference, next-generation sequencing (NGS) and bioinformatics. Utilising CRISPR/Cas9 and RNAi technologies, we conduct functional studies in tailored cellular assays targeting single genes, gene panels and whole-genome screening. Our integrated NGS facility supports various applications, such as DNA, RNA and amplicon sequencing. We are also a certified provider of 10x Genomics single-cell sequencing.
Explore the lipid nanoparticle (LNP) and virus delivery platform at Nuvisan.
learn moreWe showcase an example for the use of CRISPR in drug target deconvolution.
DownloadCheck out a summary of our comprehensive next-generation sequencing (NGS) services.
download